publicações selecionadas
-
artigo académico
- Multifunctional Hyaluronic Acid/Graphite Nanoplatelet Hydrogels as Tools for Spinal Cord Regeneration. ACS Applied Materials and Interfaces. 2025
- Mussel-Inspired Hydrogels Incorporating Graphite Derivatives for Soft Tissue Regeneration. Nanomaterials. 2025
- Development and in vitro assessment of injectable, adhesive, and self-healing chitosan-based hydrogels for treatment of spinal cord injury. Biomaterials Advances. 2025
- Antibacterial properties of photo-crosslinked chitosan/methacrylated hyaluronic acid nanoparticles loaded with bacitracin. International Journal of Biological Macromolecules. 2024
- Bioadhesive Hyaluronic Acid-Based Hydrogels for Spinal Cord Injury. Biomacromolecules. 2024
- Bioadhesive Hyaluronic Acid-Based Hydrogels for Spinal Cord Injury. Biomacromolecules. 2024
- Biocompatible 3D-Printed Tendon/Ligament Scaffolds Based on Polylactic Acid/Graphite Nanoplatelet Composites. Nanomaterials. 2023
- Adhesive and Antibacterial Films Based on Marine-Derived Fucoidan and Chitosan. ACS Sustainable Chemistry and Engineering. 2022
- Adhesive and Antibacterial Films Based on Marine-Derived Fucoidan and Chitosan. ACS Sustainable Chemistry and Engineering. 2022
- Adhesive and biodegradable membranes made of sustainable catechol-functionalized marine collagen and chitosan. Colloids and Surfaces B: Biointerfaces. 2022
- Adhesive and biodegradable membranes made of sustainable catechol-functionalized marine collagen and chitosan. Colloids and Surfaces B: Biointerfaces. 2022
- A poly-e-caprolactone based biofilm carrier for nitrate removal from water. Amino Acids. 2018
- New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: Synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death. European Journal of Medicinal Chemistry. 2013
- Regiocontrolled SNAr Reaction on 2,3-Dihalopyridines with NaSMe To Obtain Bromo(methylthio)pyridines as Key Precursors of 3-Halo-2-(hetero)arylthieno[2,3-b]pyridines and Thieno[3,2-b]pyridines. Synthesis. 2013
- Antioxidant activity of aminodiarylamines in the thieno[3,2-b]pyridine series: radical scavenging activity, lipid peroxidation inhibition and redox profile. Journal of Enzyme Inhibition and Medicinal Chemistry. 2013
- New 1,3-diarylureas linked by C-C Suzuki coupling to the methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate moiety: synthesis and fluorescence studies in solution and in lipid membranes. Journal of Photochemistry and Photobiology A-Chemistry. 2013
- 1-Aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modelling Studies. Biomed Research International. 2013
- Synthesis of 2-(hetero)arylthieno[2,3-b] or [3,2-b]pyridines from 2,3-dihalopyridines, (hetero)arylalkynes, and Na2S. Further functionalizations. Tetrahedron. 2012
- New potential antitumoral di(hetero)arylether derivatives in the thieno[3,2-b]pyridine series : synthesis and fluorescence studies in solution and in nanoliposomes. Journal of Photochemistry and Photobiology A-Chemistry. 2012
- Aminodi(hetero)arylamines in the Thieno[3,2-b]pyridine Series: Synthesis, Effects in Human Tumor Cells Growth, Cell Cycle Analysis, Apoptosis and Evaluation of Toxicity Using Non-Tumor Cells. Biomolecules. 2012
-
artigo de conferência
-
capítulo de livro
-
documento
- New Di(hetero)arylethers and Di(hetero)arylamines in the Thieno [3,2-b]pyridine Series: Synthesis, Growth Inhibitory Activity on Human Tumor Cell Lines and Nanotumor Cells, Effects on Cell Cycle And on Apoptosis 2014
- Synthesis, molecular docking and biological Evaluation of New 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas as Potent Type II CEGFR-2 Tyrosine Kinase Inhibitors 2014
- Synthesis, docking, enzymatic and cellular assays of thieno[3,2-b]pyridine-thioether-1,3-diarylureas as VEGFR2 inhibitors 2013
- Synthesis, growth inhibitory activity on human tumor cell lines and evaluation of the hepatotoxicity of di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series 2013
- Thieno[3,2-b]pyridine arylethers: synthesis and growth inhibitory activity on human tumor cell lines 2013
- Heteroarylether 1,3-diarylureas in the thieno[3,2-d]pyrimidine series as VEGFR2 tyrosine kinase inhibitors: synthesis, docking studies, enzymatic and cellular assays 2013
- Synthesis of thienopyridine derivatives as potential antitumorals and/or antiangiogenics 2013
- 1-Aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR2 inhibitors: synthesis, docking enzymatic and cellular assays 2012
- Fluorescence studies on new potential antitumoral 1,3-diarylurea derivatives in the thieno[3,2-b]pyridine series encapsulated in magnetoliposomes 2012
- 1-Aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR2 tyrosine kinase inhibitors: synthesis, docking, studies, enzymatic and cellular assays 2012
- Synthesis of 3-Halo-2-(Hetero)Arylthienopyridines through a three-step methodology from 2,3-Dihalopyridines, Methanethiolate, (Hetero)Arylalkynes and Electrophiles 2012
- Synthesis of Di(Hetero)Arylamines and Ethers in the Thieno[3,2-b]Pyridine series by Metal-Catalyzed couplings 2012
- Synthesis of Tetracyclic systems and (Thio)Ureas from Aminodi(Hetero)Arylamines in the Thieno[3,2-b]Pyridine series 2012
- Synthesis of novel 1-Aryl-3-[2-,3- Or 4-(Thieno[3,2-b]Pyridin-7-Ylthio)Phenyl]Ureas and evaluation as VEGFR2 Tyrosine kinase inhibitors 2012
- Fluorescence studies on new potential antitumoral 1,3-diarylurea derivatives of thieno[3,2-b]pyridines in solution and in nanoliposomes 2011
- Synthesis of 1,3-diaryl(thio)ureas in the thieno[3,2-b]pyridine series by palladium-catalyzed couplings and reactions with aryliso(thio)cyanates 2011
- Synthesis of 1,3-diarylureas from different (thieno3,2-b]pyridin-7-ylthio)anilines 2011
- Synthesis of di(hetero)arylethers in the thieno[3,2-b]pyridine series by copper/N,N-dimethylglycine catalysed C-O coupling 2011
- Síntese de novos derivados de tienopiridinas como potenciais anti-tumorais e/ou anti-angiogénicos 2011